NASDAQ: INKTMink Therapeutics Inc Stock Ownership - Who owns Mink Therapeutics?
Insider buying vs selling
Have Mink Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ulf Wiinberg | Director | 2024-12-01 | 20,476 | $0.73 | $14.95kBuy |
| Peter Behner | Director | 2024-12-01 | 20,987 | $0.73 | $15.32kBuy |
| Brian Corvese | Director | 2024-12-01 | 24,400 | $0.73 | $17.81kBuy |
| Robert Peter Kadlec | Director | 2024-12-01 | 12,286 | $0.73 | $8.97kBuy |
| Barbara Ryan | Director | 2024-12-01 | 24,229 | $0.73 | $17.69kBuy |
| Peter Behner | Director | 2024-09-03 | 18,753 | $0.82 | $15.38kBuy |
| Brian Corvese | Director | 2024-09-03 | 21,802 | $0.82 | $17.88kBuy |
| Barbara Ryan | Director | 2024-09-03 | 21,649 | $0.82 | $17.75kBuy |
| Ulf Wiinberg | Director | 2024-09-03 | 18,295 | $0.82 | $15.00kBuy |
| Brian Corvese | Director | 2024-06-03 | 17,967 | $0.99 | $17.79kBuy |
INKT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INKT insiders and whales buy or sell their stock.
INKT Shareholders
What type of owners hold Mink Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Agenus Inc | 55.05% | 21,772,863 | $18.51M | Insider |
| Garo H. Armen | 4.97% | 1,966,400 | $1.67M | Insider |
| Brian Corvese | 1.08% | 426,283 | $362.34k | Insider |
| Ulf Wiinberg | 1.07% | 422,481 | $359.11k | Insider |
| Vanguard Group Inc | 0.59% | 234,182 | $199.05k | Institution |
| Jennifer Buell | 0.59% | 232,165 | $197.34k | Insider |
| Longbow Finance Sa | 0.42% | 166,666 | $141.67k | Institution |
| Barbara Ryan | 0.38% | 150,336 | $127.79k | Insider |
| Peter Behner | 0.34% | 133,634 | $113.59k | Insider |
| Renaissance Technologies LLC | 0.27% | 106,687 | $90.68k | Institution |
INKT vs Biotech Stocks
Mink Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.